nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—HTR2A—narcolepsy	0.765	1	CbGaD
Lurasidone—HTR7—enteric nervous system—narcolepsy	0.0235	0.192	CbGeAlD
Lurasidone—HTR7—locus ceruleus—narcolepsy	0.0155	0.127	CbGeAlD
Lurasidone—HTR2A—enteric nervous system—narcolepsy	0.0146	0.12	CbGeAlD
Lurasidone—HTR2A—locus ceruleus—narcolepsy	0.00966	0.0792	CbGeAlD
Lurasidone—HTR7—pons—narcolepsy	0.00892	0.0732	CbGeAlD
Lurasidone—HTR7—autonomic nervous system—narcolepsy	0.00823	0.0675	CbGeAlD
Lurasidone—HTR2A—pons—narcolepsy	0.00557	0.0456	CbGeAlD
Lurasidone—HTR2A—autonomic nervous system—narcolepsy	0.00513	0.0421	CbGeAlD
Lurasidone—Ziprasidone—HTR2A—narcolepsy	0.00231	1	CrCbGaD
Lurasidone—HTR1A—brainstem—narcolepsy	0.00208	0.017	CbGeAlD
Lurasidone—HTR1A—forebrain—narcolepsy	0.00201	0.0164	CbGeAlD
Lurasidone—HTR7—brainstem—narcolepsy	0.00199	0.0163	CbGeAlD
Lurasidone—HTR7—forebrain—narcolepsy	0.00192	0.0157	CbGeAlD
Lurasidone—DRD2—brainstem—narcolepsy	0.00188	0.0154	CbGeAlD
Lurasidone—DRD2—forebrain—narcolepsy	0.00181	0.0149	CbGeAlD
Lurasidone—ADRA2A—forebrain—narcolepsy	0.00141	0.0115	CbGeAlD
Lurasidone—HTR7—medulla oblongata—narcolepsy	0.00139	0.0114	CbGeAlD
Lurasidone—HTR1A—midbrain—narcolepsy	0.00133	0.0109	CbGeAlD
Lurasidone—ADRA2C—medulla oblongata—narcolepsy	0.00127	0.0104	CbGeAlD
Lurasidone—HTR7—midbrain—narcolepsy	0.00127	0.0104	CbGeAlD
Lurasidone—HTR2A—brainstem—narcolepsy	0.00124	0.0102	CbGeAlD
Lurasidone—DRD2—midbrain—narcolepsy	0.0012	0.00981	CbGeAlD
Lurasidone—HTR2A—forebrain—narcolepsy	0.0012	0.0098	CbGeAlD
Lurasidone—ADRA2C—midbrain—narcolepsy	0.00116	0.00954	CbGeAlD
Lurasidone—ADRA2A—medulla oblongata—narcolepsy	0.00102	0.00833	CbGeAlD
Lurasidone—ADRA2A—midbrain—narcolepsy	0.000929	0.00761	CbGeAlD
Lurasidone—HTR2A—medulla oblongata—narcolepsy	0.000864	0.00708	CbGeAlD
Lurasidone—HTR1A—brain—narcolepsy	0.000833	0.00682	CbGeAlD
Lurasidone—HTR7—brain—narcolepsy	0.000796	0.00652	CbGeAlD
Lurasidone—HTR2A—midbrain—narcolepsy	0.00079	0.00647	CbGeAlD
Lurasidone—DRD2—brain—narcolepsy	0.000752	0.00617	CbGeAlD
Lurasidone—ADRA2C—brain—narcolepsy	0.000731	0.00599	CbGeAlD
Lurasidone—ADRA2A—brain—narcolepsy	0.000584	0.00478	CbGeAlD
Lurasidone—HTR2A—brain—narcolepsy	0.000496	0.00407	CbGeAlD
Lurasidone—HTR2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000278	0.00252	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—HCRT—narcolepsy	0.000278	0.00251	CbGpPWpGaD
Lurasidone—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000276	0.0025	CbGpPWpGaD
Lurasidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000276	0.0025	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—HCRT—narcolepsy	0.000273	0.00247	CbGpPWpGaD
Lurasidone—ADRA2A—G alpha (i) signalling events—HRH3—narcolepsy	0.000273	0.00247	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—PENK—narcolepsy	0.000273	0.00247	CbGpPWpGaD
Lurasidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000272	0.00246	CbGpPWpGaD
Lurasidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000267	0.00241	CbGpPWpGaD
Lurasidone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000267	0.00241	CbGpPWpGaD
Lurasidone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000267	0.00241	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—HCRTR1—narcolepsy	0.000267	0.00241	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—HCRTR2—narcolepsy	0.000267	0.00241	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—P2RY11—narcolepsy	0.000258	0.00233	CbGpPWpGaD
Lurasidone—ADRA2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000253	0.00229	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—HCRT—narcolepsy	0.000249	0.00225	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—PENK—narcolepsy	0.000248	0.00224	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000247	0.00224	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—PENK—narcolepsy	0.000244	0.0022	CbGpPWpGaD
Lurasidone—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000242	0.00219	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—HCRT—narcolepsy	0.000241	0.00218	CbGpPWpGaD
Lurasidone—HTR1A—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00024	0.00217	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—TRH—narcolepsy	0.00024	0.00217	CbGpPWpGaD
Lurasidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000238	0.00216	CbGpPWpGaD
Lurasidone—HTR7—GPCR ligand binding—TAC1—narcolepsy	0.000235	0.00213	CbGpPWpGaD
Lurasidone—HTR7—GPCR ligand binding—NPS—narcolepsy	0.000235	0.00213	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—TRH—narcolepsy	0.000232	0.0021	CbGpPWpGaD
Lurasidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000229	0.00207	CbGpPWpGaD
Lurasidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000229	0.00207	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—PENK—narcolepsy	0.000222	0.002	CbGpPWpGaD
Lurasidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000221	0.002	CbGpPWpGaD
Lurasidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000221	0.002	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—HCRT—narcolepsy	0.000219	0.00198	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000218	0.00197	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000218	0.00197	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000217	0.00196	CbGpPWpGaD
Lurasidone—HTR7—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000217	0.00196	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—PENK—narcolepsy	0.000215	0.00194	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—HCRTR2—narcolepsy	0.000211	0.0019	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—HCRTR1—narcolepsy	0.000211	0.0019	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—TRH—narcolepsy	0.00021	0.0019	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00021	0.0019	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—HRH3—narcolepsy	0.00021	0.0019	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—TRH—narcolepsy	0.000207	0.00187	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—P2RY11—narcolepsy	0.000203	0.00184	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—HRH3—narcolepsy	0.000203	0.00184	CbGpPWpGaD
Lurasidone—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000201	0.00182	CbGpPWpGaD
Lurasidone—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000201	0.00182	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—HCRTR1—narcolepsy	0.000198	0.00179	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—HCRTR2—narcolepsy	0.000198	0.00179	CbGpPWpGaD
Lurasidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000198	0.00179	CbGpPWpGaD
Lurasidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000198	0.00179	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—PENK—narcolepsy	0.000195	0.00177	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—HCRTR1—narcolepsy	0.000191	0.00173	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—HCRTR2—narcolepsy	0.000191	0.00173	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—HCRTR1—narcolepsy	0.000191	0.00173	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—HCRTR2—narcolepsy	0.000191	0.00173	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—P2RY11—narcolepsy	0.000191	0.00173	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—TRH—narcolepsy	0.000188	0.0017	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000188	0.0017	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000188	0.0017	CbGpPWpGaD
Lurasidone—HTR7—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000186	0.00168	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—P2RY11—narcolepsy	0.000185	0.00167	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—P2RY11—narcolepsy	0.000185	0.00167	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—HRH3—narcolepsy	0.000185	0.00167	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—TRH—narcolepsy	0.000183	0.00165	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—P2RY11—narcolepsy	0.000182	0.00164	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—HRH3—narcolepsy	0.000182	0.00164	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00018	0.00163	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00018	0.00163	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—HCRT—narcolepsy	0.000179	0.00162	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—TAC1—narcolepsy	0.000174	0.00157	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—NPS—narcolepsy	0.000174	0.00157	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—HCRTR2—narcolepsy	0.000174	0.00157	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—HCRTR1—narcolepsy	0.000174	0.00157	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—HCRT—narcolepsy	0.000173	0.00156	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000171	0.00155	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000171	0.00155	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—HCRTR2—narcolepsy	0.000171	0.00154	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—HCRTR1—narcolepsy	0.000171	0.00154	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—NPS—narcolepsy	0.000169	0.00152	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—TAC1—narcolepsy	0.000169	0.00152	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—P2RY11—narcolepsy	0.000168	0.00152	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—TRH—narcolepsy	0.000166	0.0015	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—P2RY11—narcolepsy	0.000165	0.00149	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—HRH3—narcolepsy	0.000165	0.00149	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—P2RY11—narcolepsy	0.000165	0.00149	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—HCRT—narcolepsy	0.000162	0.00147	CbGpPWpGaD
Lurasidone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000161	0.00145	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—HRH3—narcolepsy	0.00016	0.00145	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—PENK—narcolepsy	0.000159	0.00144	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—HCRTR2—narcolepsy	0.000158	0.00142	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—HCRTR1—narcolepsy	0.000158	0.00142	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—HCRT—narcolepsy	0.000157	0.00142	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—HCRT—narcolepsy	0.000157	0.00142	CbGpPWpGaD
Lurasidone—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000155	0.00141	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—HCRTR1—narcolepsy	0.000155	0.0014	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—HCRTR2—narcolepsy	0.000155	0.0014	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—HCRT—narcolepsy	0.000154	0.0014	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—PENK—narcolepsy	0.000154	0.00139	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CHKB—narcolepsy	0.000153	0.00139	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—TAC1—narcolepsy	0.000153	0.00138	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—NPS—narcolepsy	0.000153	0.00138	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—P2RY11—narcolepsy	0.000152	0.00138	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—TAC1—narcolepsy	0.00015	0.00136	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—NPS—narcolepsy	0.00015	0.00136	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—P2RY11—narcolepsy	0.00015	0.00136	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—HRH3—narcolepsy	0.000146	0.00132	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—PENK—narcolepsy	0.000145	0.00131	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—HCRT—narcolepsy	0.000143	0.00129	CbGpPWpGaD
Lurasidone—HTR7—GPCR ligand binding—HTR2A—narcolepsy	0.000141	0.00128	CbGpPWpGaD
Lurasidone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000141	0.00127	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—HCRT—narcolepsy	0.00014	0.00127	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—HCRT—narcolepsy	0.00014	0.00127	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—PENK—narcolepsy	0.00014	0.00127	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—PENK—narcolepsy	0.00014	0.00126	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—PENK—narcolepsy	0.000138	0.00124	CbGpPWpGaD
Lurasidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000138	0.00124	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—TAC1—narcolepsy	0.000137	0.00124	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—NPS—narcolepsy	0.000137	0.00124	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—TRH—narcolepsy	0.000135	0.00122	CbGpPWpGaD
Lurasidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000133	0.0012	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—NPS—narcolepsy	0.000133	0.0012	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—TAC1—narcolepsy	0.000133	0.0012	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—TRH—narcolepsy	0.000131	0.00119	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—HCRT—narcolepsy	0.000129	0.00117	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—HCRT—narcolepsy	0.000128	0.00115	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—PENK—narcolepsy	0.000127	0.00115	CbGpPWpGaD
Lurasidone—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000126	0.00114	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—PENK—narcolepsy	0.000125	0.00113	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—PENK—narcolepsy	0.000125	0.00113	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CHKB—narcolepsy	0.000125	0.00113	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—TRH—narcolepsy	0.000123	0.00111	CbGpPWpGaD
Lurasidone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000121	0.00109	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—TAC1—narcolepsy	0.000121	0.00109	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—NPS—narcolepsy	0.000121	0.00109	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—TRH—narcolepsy	0.000119	0.00108	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—TRH—narcolepsy	0.000119	0.00108	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—HRH3—narcolepsy	0.000119	0.00107	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—TRH—narcolepsy	0.000117	0.00106	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HCRTR1—narcolepsy	0.000117	0.00106	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HCRTR2—narcolepsy	0.000117	0.00106	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—PENK—narcolepsy	0.000115	0.00104	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—HRH3—narcolepsy	0.000115	0.00104	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—PENK—narcolepsy	0.000114	0.00103	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HCRTR1—narcolepsy	0.000113	0.00102	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HCRTR2—narcolepsy	0.000113	0.00102	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—P2RY11—narcolepsy	0.000113	0.00102	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—P2RY11—narcolepsy	0.000109	0.000987	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000108	0.000978	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—TRH—narcolepsy	0.000108	0.000977	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—HRH3—narcolepsy	0.000108	0.000975	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—TRH—narcolepsy	0.000106	0.000963	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—TRH—narcolepsy	0.000106	0.000961	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—HTR2A—narcolepsy	0.000105	0.000947	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—HRH3—narcolepsy	0.000104	0.000944	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CPT1B—narcolepsy	0.000104	0.000943	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—HRH3—narcolepsy	0.000104	0.000943	CbGpPWpGaD
Lurasidone—HTR1A—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000103	0.000934	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—HRH3—narcolepsy	0.000103	0.000928	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HCRTR1—narcolepsy	0.000103	0.000927	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HCRTR2—narcolepsy	0.000103	0.000927	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—HTR2A—narcolepsy	0.000101	0.000917	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HCRTR2—narcolepsy	0.000101	0.000912	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HCRTR1—narcolepsy	0.000101	0.000912	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—P2RY11—narcolepsy	9.9e-05	0.000895	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—NPS—narcolepsy	9.84e-05	0.00089	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—TAC1—narcolepsy	9.84e-05	0.00089	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—TRH—narcolepsy	9.81e-05	0.000887	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—P2RY11—narcolepsy	9.74e-05	0.000881	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—TRH—narcolepsy	9.67e-05	0.000874	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HCRT—narcolepsy	9.59e-05	0.000867	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—NPS—narcolepsy	9.52e-05	0.000861	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—TAC1—narcolepsy	9.52e-05	0.000861	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—HRH3—narcolepsy	9.47e-05	0.000856	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—HRH3—narcolepsy	9.34e-05	0.000844	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—HRH3—narcolepsy	9.32e-05	0.000843	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HCRT—narcolepsy	9.28e-05	0.000839	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—HTR2A—narcolepsy	9.2e-05	0.000832	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HCRTR1—narcolepsy	9.18e-05	0.00083	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HCRTR2—narcolepsy	9.18e-05	0.00083	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—TAC1—narcolepsy	8.94e-05	0.000808	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—NPS—narcolepsy	8.94e-05	0.000808	CbGpPWpGaD
Lurasidone—HTR2A—SIDS Susceptibility Pathways—TNF—narcolepsy	8.92e-05	0.000807	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—P2RY11—narcolepsy	8.86e-05	0.000801	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—NPS—narcolepsy	8.65e-05	0.000782	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—TAC1—narcolepsy	8.65e-05	0.000782	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—TAC1—narcolepsy	8.64e-05	0.000781	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—NPS—narcolepsy	8.64e-05	0.000781	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—HRH3—narcolepsy	8.6e-05	0.000777	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PENK—narcolepsy	8.55e-05	0.000773	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—TAC1—narcolepsy	8.5e-05	0.000769	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—NPS—narcolepsy	8.5e-05	0.000769	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—HRH3—narcolepsy	8.48e-05	0.000767	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CPT1B—narcolepsy	8.47e-05	0.000766	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HCRT—narcolepsy	8.42e-05	0.000761	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HCRT—narcolepsy	8.28e-05	0.000749	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PENK—narcolepsy	8.27e-05	0.000748	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—HTR2A—narcolepsy	8.23e-05	0.000745	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—HTR2A—narcolepsy	7.99e-05	0.000722	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—TAC1—narcolepsy	7.85e-05	0.00071	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—NPS—narcolepsy	7.85e-05	0.00071	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—TAC1—narcolepsy	7.74e-05	0.000699	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—NPS—narcolepsy	7.74e-05	0.000699	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—TAC1—narcolepsy	7.72e-05	0.000698	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—NPS—narcolepsy	7.72e-05	0.000698	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HCRT—narcolepsy	7.54e-05	0.000681	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PENK—narcolepsy	7.5e-05	0.000678	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PENK—narcolepsy	7.38e-05	0.000668	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TRH—narcolepsy	7.27e-05	0.000657	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—HTR2A—narcolepsy	7.26e-05	0.000656	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NPS—narcolepsy	7.12e-05	0.000644	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—TAC1—narcolepsy	7.12e-05	0.000644	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TRH—narcolepsy	7.03e-05	0.000636	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—TAC1—narcolepsy	7.02e-05	0.000635	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—NPS—narcolepsy	7.02e-05	0.000635	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PENK—narcolepsy	6.72e-05	0.000607	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TRH—narcolepsy	6.38e-05	0.000577	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HRH3—narcolepsy	6.37e-05	0.000576	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TRH—narcolepsy	6.28e-05	0.000568	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HRH3—narcolepsy	6.17e-05	0.000558	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—HTR2A—narcolepsy	5.92e-05	0.000535	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—HTR2A—narcolepsy	5.73e-05	0.000518	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TRH—narcolepsy	5.71e-05	0.000516	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HRH3—narcolepsy	5.59e-05	0.000506	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HRH3—narcolepsy	5.5e-05	0.000498	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—HTR2A—narcolepsy	5.38e-05	0.000486	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CHKB—narcolepsy	5.31e-05	0.00048	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NPS—narcolepsy	5.28e-05	0.000477	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TAC1—narcolepsy	5.28e-05	0.000477	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—HTR2A—narcolepsy	5.2e-05	0.00047	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—HTR2A—narcolepsy	5.2e-05	0.00047	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TAC1—narcolepsy	5.11e-05	0.000462	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NPS—narcolepsy	5.11e-05	0.000462	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HRH3—narcolepsy	5.01e-05	0.000453	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—HTR2A—narcolepsy	4.72e-05	0.000427	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—HTR2A—narcolepsy	4.65e-05	0.000421	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TAC1—narcolepsy	4.64e-05	0.000419	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NPS—narcolepsy	4.64e-05	0.000419	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NPS—narcolepsy	4.56e-05	0.000412	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TAC1—narcolepsy	4.56e-05	0.000412	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—HTR2A—narcolepsy	4.29e-05	0.000388	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—HTR2A—narcolepsy	4.23e-05	0.000382	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NPS—narcolepsy	4.15e-05	0.000375	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TAC1—narcolepsy	4.15e-05	0.000375	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CPT1B—narcolepsy	3.61e-05	0.000326	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HTR2A—narcolepsy	3.18e-05	0.000287	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HTR2A—narcolepsy	3.07e-05	0.000278	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HTR2A—narcolepsy	2.79e-05	0.000252	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HTR2A—narcolepsy	2.5e-05	0.000226	CbGpPWpGaD
